Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04404725 · ClinicalTrials.gov registry record · NA
Comparing Biofinity Toric Multifocal to Ultra Multifocal for Astigmatism
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT04404725 is a NA study that has completed, run by CooperVision. The registered enrollment target is 64 participants.
The verdict
NCT04404725, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The objective of the study was to compare the handling and performance of Biofinity Toric Multifocal to Ultra Multifocal for Astigmatism.
Interventions
- DEVICE comfilcon A
- DEVICE Samfilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2020-08-06 |
| Est. Completion | 2021-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04404725
The ClinicalTrials.gov registry entry for NCT04404725 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which comfilcon A is the first listed.
NCT04404725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04404725 about?
NCT04404725 is a clinical study titled "Comparing Biofinity Toric Multifocal to Ultra Multifocal for Astigmatism". The objective of the study was to compare the handling and performance of Biofinity Toric Multifocal to Ultra Multifocal for Astigmatism.
What is the current status of trial NCT04404725?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2020-08-06. Estimated completion is 2021-07-29.
What interventions are being tested in trial NCT04404725?
The interventions under investigation include: comfilcon A (DEVICE), Samfilcon A (DEVICE).
Who is sponsoring clinical trial NCT04404725?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.